Despite the up regulation of H3K4me3 observed in vitro, APL patients presented only a modest increase for H3K4me3 and H3K27ac at the MLL5 locus upon ATRA treatment17,21. The gene discussed is KMT2E; the disease is acute promyelocytic leukemia.